Could Difficult-to-treat Hypertension Be a Predictor of Bad Outcome in Ischemic Stroke?

被引：0
|
作者：
Machado, Pedro Colla
Zurru, Maria C.
Luzzi, Ariel
Brescacin, Laura
Alonzo, Claudia
Camera, Luis
Waisman, Gabriel
Cristiano, Edgardo
机构：
来源：
STROKE | 2015年 / 46卷
关键词：
Hypertension; Risk factors;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATMP39
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice
    Baldo, Guilherme
    Mayer, Fabiana Q.
    Martinelli, Barbara Z.
    de Carvalho, Talita G.
    Meyer, Fabiola S.
    de Oliveira, Patricia G.
    Meurer, Luise
    Tavares, Angela
    Matte, Ursula
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2013, 109 (01) : 33 - 40
  • [32] Plasma Renin Activity Testing to Guide Triple Antirenin System Drug Therapy in a Patient With Difficult-to-Treat Hypertension
    Shah, Sachil
    Coakley, Christina
    Hough, Augustus
    Parra, David
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1562 - 1568
  • [33] Plasma Renin Activity Testing to Guide Triple Antirenin System Drug Therapy in a Patient With Difficult-to-Treat Hypertension
    Shah, Sachil
    Coakley, Christina
    Hough, Augustus
    Parra, David
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (02) : 279 - 285
  • [34] Combination Therapy for Managing Difficult-to-Treat Patients With Stage 2 Hypertension: Focus on Valsartan-Based Combinations
    Weintraub, Howard S.
    Rudolph, Amy
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (06) : E227 - E243
  • [35] Difficult-to-treat ascitic fluid infection is a predictor of transplant-free survival in childhood decompensated chronic liver disease
    Mahajan, Supriya
    Lal, Bikrant Bihari
    Sood, Vikrant
    Khillan, Vikas
    Khanna, Rajeev
    Alam, Seema
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2020, 39 (05) : 465 - 472
  • [36] Difficult-to-treat ascitic fluid infection is a predictor of transplant-free survival in childhood decompensated chronic liver disease
    Supriya Mahajan
    Bikrant Bihari Lal
    Vikrant Sood
    Vikas Khillan
    Rajeev Khanna
    Seema Alam
    Indian Journal of Gastroenterology, 2020, 39 : 465 - 472
  • [37] Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
    Ochi, Sae
    Sonomoto, Koshiro
    Nakayamada, Shingo
    Tanaka, Yoshiya
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [38] Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
    Sae Ochi
    Koshiro Sonomoto
    Shingo Nakayamada
    Yoshiya Tanaka
    Arthritis Research & Therapy, 24
  • [39] Transdermal clonidine in difficult-to-treat hypertension patients attending a specialist blood pressure (BP) clinic in the United Kingdom
    Kapil, Vikas
    Louthan, Jessica
    Hamedi, Nadya
    Alom, Rahana
    Antoniou, Sotiris
    Lobo, Melvin
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (10) : 664 - 665
  • [40] Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trial
    Oliveras, Anna
    Vazquez, Susana
    Vega, Maria Victoria
    Camps, Carme
    Illana, Francisco J.
    Armario, Pedro
    Crespo, Marta
    de la Sierra, Alejandro
    HYPERTENSION RESEARCH, 2024, : 2864 - 2873
12345